About us
Vision & Mission
C4Diagnostics is developing in vitro diagnostics kits based on its proprietary technology, with the following specifications in mind:
Simple for the lab, fast and accurate for the patient and the medical community: actionable medical information for medical professionals.
C4Diagnostics aims at disrupting the global market of infectious diseases IVD by:
- Delivering faster highly sensitive results
- Addressing unmet medical needs
C4Diagnostics develops and commercializes IVD kits based on its proprietary, versatile, phenotypic and simple technology.
History
Our Commitments
ISO 13485 standards
C4Diagnostics commits to deliver accurate medical information with products designed and manufactured according to the highest standards.
Lloyd’s Registrer (Notified Body) ISO 13485:2016 certified C4Dx in January 2019
Team
C4Diagnostics’ management team has significant and complementary experience in the development, implementation, and commercialization of infectious diseases in vitro diagnostics.
Today, the C4Diagnostics’ team includes 19 persons.
Heads of
Younes Lazrak
Founder & CEO
Before cofounding C4Diagnostics, Younes worked in Business Development and IP management in several in vitro diagnostics companies (Incl. Ipsogen & Qiagen), with an impressive track record. His main responsibilities were Licensing in & out and the management of the industrial intellectual ownership, before progressively shifting to Business development and alliances management.
Thomas Tran, MBA
Vice President Marketing & Sales EMEA
With a scientific background supplemented by a Master’s degree in General Management International, Thomas has successfully held various key management roles in business development, sales and marketing within PME(s) and Top5 leading companies in IVD. Experienced commercial business leader in B2B and B2C sales, Thomas joined C4Diagnostics’s team in May 2020 with the responsibility of organizing and developing the marketing and global sales activity.
Damien Thomas
Head of R&D and Industrialization
After a PhD in microbiology and immunology, Damien has worked in different IVD private companies. For Ingen/Eurobio, Damien was in charge of R&D and Industrialization teams. Then, he managed the Manufacturing, Quality Control, Logistic team’s for Theradiag and Operation management for IDS. He joined in the summer 2019 C4Diagnostics as Head of R&D and Industrialization.
Thierry Maunier
Head of Quality & Regulatory Affairs
Quality Engineer & M.Sc. in Microbiology and Immunology, Thierry served as Quality Assurance and Quality Control Manager in various Medical Device design and manufacturing companies. Quality Systems he implemented and managed have efficiently fulfilled international standards (ISO13485, ISO9001) & International Regulation requirements (MDR, MDIVD, 21CFRs, SOR).
Émilie Fugier
Founder & R&D Project Manager / Board member
PhD in microbiology and immunology, Emilie has managed various scientific projects involving different pathogenic organisms with industries (CHEMUNEX) and hospitals (CHU Grenoble, Hôpital St-Joseph Marseille). In 2012, she joined Sam Dukan’s team in the CNRS to work on the technology used by C4Diagnostics. She is now collaborating on all R&D projects.
Executive profils of C4Diagnostics : Thierry Maunier, Younes Lazrak, Emilie Fugier, Thomas Tran, Gaël Combemale, Damien Thomas
Board & Advisors
Gaël Combemale
Chief Financial Officer
With a Master in Business management and Administration, Gaël has 5 years of experience in ERP, as well as 6 years in corporate financial management. Since January 2020, he joined the C4Diagnostics’ team and manages of all the financial aspects.
Sam Dukan
Founder & Scientific Advisor
Former student of the Ecole Normale Supérieure in Paris, then research director leading a team of up to 12 people in CNRS (National Center of Scientifical research), Sam has worked during his all career within big groups like Suez Environnement or CIBA, on application challenges, witnessing technical and operationnal adaptability. Author of 45 scientific publications and co-inventor of 8 patents, Sam is scientifically advising the C4Diagnostics’ projects. He is also the CEO of Diamidex.
Hélène PEYRO-ST-PAUL
Medical Affairs
Medical Affairs – 20+ years exp.
Independant (former Qiagen, EMD Serono)
Amine BOUKOUSS
Board member
Investment and growth capital – 5 years exp.
Associate (Turenne Capital)
Oriane BURLAT
Board member
Finance – 10 years exp.
Advisor in Innovation Management
Jean-François GRENIER
Market Access
Strategy advisor – 25+ years exp.
Angels santé (former Bayer, Bristol-Myers Squib)
Pierre CHAVAGNE
Board member
Accounting management – 20+ years exp.
General Manager (Cisbio Bioassays)
Andrei POLUKHTIN
Board member
Managing Director (Click Chemistry Tools)
Armand PERRIN
Board member
FInance – 30+ years exp.
Investment Manager (CAAP Création)
